language_icon
EN
HI

Fischer Medical Ventures Share price

FISCHER

34.76

0.28 (-0.80%)
NSE
BSE
Last updated on 21 May, 2026 | 15:31 IST
Today's High

36.49

Today's Low

34.60

52 Week Low

32.01

52 Week High

124.70

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Fischer Medical Ventures Chart

Fischer Medical Ventures Share Key Metrics

Volume
9.79 L
Market Cap
2254.24 CR
LTQ@LTP
1@34.76
ATP
35.6
Var Margin
24.54 %
Circuit Range
33.29-36.79
Delivery %
17.24 %
Value
3.49 CR
ASM/GSM
No
Market Lot
1

Summary

21 May, 2026 | 15:31 को, Fischer Medical Ventures का शेयर प्राइस आज ₹34.76 पर है, जो दिन के लिए 0.28% की -0.80 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹34.60 और ₹36.49 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹32.01 से ₹124.70 तक रही है। ट्रेडिंग गतिविधि के मामले में, Fischer Medical Ventures ने 979448 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹648515470 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹3560 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,3476 रही। यह स्टॉक ₹33.29-36.79 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹3.49 CR है। दिन के लिए डिलीवरी परसेंटेज 17.24% रही। इसके अतिरिक्त, Fischer Medical Ventures वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Fischer Medical Ventures Fundamentals

View More
P/E Ratio

58.12

P/B Ratio

5.83

Div. Yield

0.01

Sector P/E

41.96

Sector P/B

2.06

Sec. Div. Yield

79.53

Fischer Medical Ventures Resistance and Support

Pivot 35

Resistance

First Resistance

35.8

Second Resistance

36.55

Third Resistance

37.35

Support

First Support

34.25

Second Support

33.45

Third Support

32.7

Fischer Medical Ventures Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

62.15%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

4.97%

Domestic Institutional Investors

1.38%

Retail

31.5%

Others

0%

Total Promoters
MAR '26
62.15%

Fischer Medical Ventures Corporate Actions

DateAgenda
2026-01-30Quarterly Results

Fischer Medical Ventures News

Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Fischer Medical Ventures' Monitoring Agency Report for Q4 FY26 confirms that funds from the preferential issue, totaling Rs.280.93 crore, were utilized as per the stated objectives with nil deviation. This includes Rs.10.53 crore used for general corporate purposes, specifically loan repayment to TMVIPL.
May 15 2026 18:05:00

Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Fischer Medical Ventures' subsidiary, Time Medical International Ventures (India) Pvt. Ltd., has partnered with the WFNS Innovation & Technology Committee. This collaboration marks the first time WFNS has formally partnered with an industry player, focusing on advancing neurosurgical care through advanced medical imaging and technology.
May 14 2026 12:05:00

About Fischer Medical Ventures AboutThe

NSE : 757658  
BSE : 524743  
ISIN : INE771F01041  

The Company was incorporated as a Public Limited Company on 22nd March 1993 and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemi- cals particularly after the delicensing of the industry the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufac- turing of Laboratory Grade Chemicals for about 10 years. The salient features of the takeover agreement with the firm and the financial results of the firm for the years 90-91 91-92 92- 93 and for the period up to 18th January 1994 are given below: Financial Results: (in Rupees) YEAR SALES PROFIT BEFORE TAX PROFIT DEPRECIATION PAID AFTER & TAX TAX 1990-91 6397551 542583 - 542583 1991-92 7393116 382709 12746 369963 1992-93 9723664 238553 40183 198370 1993-94 9318809 139406 - 139406 (till 18.1.94) Note: 1. No depreciation has been provided in the books of accounts of the firm during the above period. 2A. Depreciation under SLM for the above period (i.e) 1990-91 1991-92 and 1992-93 were Rs.75473.41 Rs.125448.92 and Rs.128729.25 respectively. 2B. Had the depreciation been provided in the book of accounts net profit for the years 1990-91 1991-92 1992-93 and 1993-94 would be Rs.467109.59 Rs.244514.08 Rs.69640.75 and Rs.139406.00 respectively. 4) Valuation of intangible assets of the firm The erstwhile partnership firm M/s Fischer Inorganics & Aromat- ics had created certain assets of intangible nature in their books of accounts for the period ended 18.01.94. The value of these assets have been arrived at as per the methods prescribed in the Memorandum of Agreement entered into between the partners of the firm. These assets have been characterised as "Technology Information" "product Approvals" "Trade Mark and Brand Name" and "R&D Standards" in the books of the firm. 6) Mode of payment for consideration 582000 equity shares of Rs.10/- each of the Company aggregating to Rs.58.20 lacs have been allotted on 19.2.94 to the partners of the firm viz. 1) Mr. G. M. Sankaranarayanan (194000 shares) 2) Mr. S.Gopalakrishnan (194000 shares) & 3) Mr.K. Vasudevan (194000 shares) towards purchase consideration. The Partnership deed is available for lnspection at the Regis- tered Office of the Company. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS SOLVENTS & ACIDS which include 1) Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2) Electronic Reagent Grade Chemicals (EL Grade) used in the Pro- cess of both Manufacturing & Assembling Electronic Industries. 3) IP Grade Chemicals used in Pharmaceutical Industries. 4) Diagnostic Grade Chemicals used in Hospitals/Clinical Labora- tories for either Bio-Chemical or Histopathological Estimations. Present installed capacity per annum: Salt 60 MT Solvents 120 KL Acids 60 KL Present capacity utilisation 90% The Company is now setting up a new plant at Kakkalur with a larger capacity to manufacture existing Grades of chemicals. The present capacity of the Various Grades of SALTS SOLVENTS & ACIDS are given below alongwith the proposed capacity for the expansion Project envisaged under this Public Issue: CAPACITY (per annum) PRODUCT PRESENT PROPOSED TOTAL Salt (Tonne) 60 840 900 Solvent (Kilo.Lt.) 120 480 600 Acid (Kilo Lt.) 60 240 300 SUBSIDIARY COMPANY The company has no Subsidiary.

Read More

Fischer Medical Ventures Management

NamePosition
Ravindran GovindanChairman & Managing Director
Svetlana Rao RaviwadaWhole Time Director
View More

Fischer Medical Ventures FAQs

Fischer Medical Ventures शेयर का खरीद मूल्य 34.76 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Fischer Medical Ventures शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Fischer Medical Ventures शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 58.12 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Fischer Medical Ventures शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.83 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Fischer Medical Ventures शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.06 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Fischer Medical Ventures का मार्केट कैप 2254.24 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Fischer Medical Ventures शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 124.70 और 32.01 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost